PLoS ONE (Jan 2019)

Racial discrimination in medical care settings and opioid pain reliever misuse in a U.S. cohort: 1992 to 2015.

  • Samuel L Swift,
  • M Maria Glymour,
  • Tali Elfassy,
  • Cora Lewis,
  • Catarina I Kiefe,
  • Stephen Sidney,
  • Sebastian Calonico,
  • Daniel Feaster,
  • Zinzi Bailey,
  • Adina Zeki Al Hazzouri

DOI
https://doi.org/10.1371/journal.pone.0226490
Journal volume & issue
Vol. 14, no. 12
p. e0226490

Abstract

Read online

BackgroundIn the United States whites are more likely to misuse opioid pain relievers (OPRs) than blacks, and blacks are less likely to be prescribed OPRs than whites. Our objective is to determine whether racial discrimination in medical settings is protective for blacks against OPR misuse, thus mediating the black-white disparities in OPR misuse.MethodsWe used data from 3528 black and white adults in the Coronary Artery Risk Development in Young Adults (CARDIA) study, an ongoing multi-site cohort. We employ causal mediation methods, with race (black vs white) as the exposure, lifetime discrimination in medical settings prior to year 2000 as the mediator, and OPR misuse after 2000 as the outcome.ResultsWe found black participants were more likely to report discrimination in a medical setting (20.3% vs 0.9%) and less likely to report OPR misuse (5.8% vs 8.0%, OR = 0.71, 95% CI = 0.55, 0.93, adjusted for covariates). Our mediation models suggest that when everyone is not discriminated against, the disparity is wider with black persons having even lower odds of reporting OPR misuse (OR = 0.63, 95% CI = 0.45, 0.89) compared to their white counterparts, suggesting racial discrimination in medical settings is a risk factor for OPR misuse rather than protective.ConclusionsThese results suggest that racial discrimination in a medical setting is a risk factor for OPR misuse rather than being protective, and thus could not explain the seen black-white disparity in OPR misuse.